ArticleCardiovascular diabetology2019

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.

Chenguang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.